ABBVIE ACCESS Trademark

Trademark Overview


On Monday, February 1, 2021, a trademark application was filed for ABBVIE ACCESS with the United States Patent and Trademark Office. The USPTO has given the ABBVIE ACCESS trademark a serial number of 90502713. The federal status of this trademark filing is REGISTERED as of Tuesday, July 5, 2022. This trademark is owned by AbbVie Inc.. The ABBVIE ACCESS trademark is filed in the Advertising, Business and Retail Services category with the following description:

Administration of a discount program for medical patients featuring product savings programs, product trial offers, and online tools to assist with obtaining prior authorizations and links to patient assistance programs which provide products to patients who are unable to afford the cost of their medication; providing a website featuring information on medical practice management
abbvie access

General Information


Serial Number90502713
Word MarkABBVIE ACCESS
Filing DateMonday, February 1, 2021
Status700 - REGISTERED
Status DateTuesday, July 5, 2022
Registration Number6783437
Registration DateTuesday, July 5, 2022
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 28, 2021

Trademark Statements


Goods and ServicesAdministration of a discount program for medical patients featuring product savings programs, product trial offers, and online tools to assist with obtaining prior authorizations and links to patient assistance programs which provide products to patients who are unable to afford the cost of their medication; providing a website featuring information on medical practice management
Description of MarkThe mark consists of The words "abbvie access" with a starburst shape next to the word "access" and an arrow pointing upward toward the center of the starburst.

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, May 4, 2021
Primary Code035
First Use Anywhere DateFriday, March 26, 2021
First Use In Commerce DateFriday, March 26, 2021

Trademark Owner History


Party NameAbbVie Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
US

Party NameAbbVie Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
US

Party NameAbbVie Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
US

Trademark Events


Event DateEvent Description
Thursday, February 4, 2021NEW APPLICATION ENTERED
Tuesday, May 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 5, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, August 20, 2021ASSIGNED TO EXAMINER
Monday, August 23, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, August 23, 2021EXAMINERS AMENDMENT E-MAILED
Monday, August 23, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 23, 2021EXAMINER'S AMENDMENT ENTERED
Monday, August 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 28, 2021PUBLISHED FOR OPPOSITION
Tuesday, September 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 23, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 18, 2022TEAS STATEMENT OF USE RECEIVED
Monday, May 2, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 18, 2022USE AMENDMENT FILED
Monday, May 2, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 31, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 1, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 5, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, July 5, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, July 6, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 6, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 6, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 6, 2026TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS